Tag: off-label

06/03/2014

House Committee Seeks Patient Input on Availability of Treatments

05/22/2014

New Yorker Article Weighs Sales Rep Free Speech Arguments in Off-label Context

05/19/2014

WLF: FDA’s Revised Reprint Draft Guidance Violates Injunction and First Amendment

04/28/2014

FDA Willing to “Re-examine” Off-label Policies in Light of First Amendment Rulings

03/31/2014

Kamp to WSJ: FDA Could Do a Better Job of Defending Off-label Limits

01/27/2014

Caronia Decision One Year Later: Off-label Change May Be Slow, But It’s Brewing

01/03/2014

Kamp on Off-label Discussion at the CMS/FDA Summit

09/16/2013

MIWG Asks FDA to Clarify Position Regarding Manufacturer Dissemination of New Use Information

05/14/2013

Kamp in MMM: Off-label Is on the Table